APA (7th ed.) Citation

Henke, W., Waisner, H., Arachchige, S. P., Kalamvoki, M., & Stephens, E. (2022). The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1). Retrovirology, 19(1), 1. https://doi.org/10.1186/s12977-022-00611-6

Chicago Style (17th ed.) Citation

Henke, Wyatt, Hope Waisner, Sachith Polpitiya Arachchige, Maria Kalamvoki, and Edward Stephens. "The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus Type 1 (HIV-1)." Retrovirology 19, no. 1 (2022): 1. https://doi.org/10.1186/s12977-022-00611-6.

MLA (9th ed.) Citation

Henke, Wyatt, et al. "The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus Type 1 (HIV-1)." Retrovirology, vol. 19, no. 1, 2022, p. 1, https://doi.org/10.1186/s12977-022-00611-6.